Xtant Cleared for Cervical Interbody System

May 21, 2018

The FDA gave Xtant 510(k) marketing clearance for its InTice-C porous titanium cervical interbody system, a scaffold material used for implant fixation.

The material is used as a bioactive scaffold and is cleared for use alongside Xtant’s proprietary allograft lines, including the company’s OsteoSponge, cortical fibers and viable cell allograft products.

InTice-C gives cervical intervertebral body fusion options for differing patient anatomies and comes in multiple footprint, height and endplate options.

View today's stories